Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alitretinoin versus cyclosporine for moderate to very severe hand eczema
NL-OMON55401Phase 3Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- May 2017
- Modality
- Small Molecules, Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hand dermatitis comparing Alitretinoin with Cyclosporine (2 arms). Primary endpoint: Response to treatment at 24 weeks. Started May 2017; status: recruiting.
02
Drugs
alitretinoincyclosporine
03
Conditions
hand dermatitis
Beyond the preview
Go deeper on NL-OMON55401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55401.